Literature DB >> 3134269

Posttransfusion hepatitis in Toronto, Canada.

S V Feinman1, B Berris, S Bojarski.   

Abstract

Five hundred seventy-six consecutive patients from the surgical, obstetrical, and medical services who had received transfusions of volunteer blood were followed-up at regular intervals for 6 mo. Fifty-three (9.2%) developed acute posttransfusion non A, non B hepatitis. Forty-seven (89%) had an incubation period between 2 and 8 wk. The frequency was not related to the age or sex of the patient, the indications for transfusion, the type of surgery, anesthesia, the presence of perioperative hypotension, or the number of units of blood transfused. There were no cases of fulminant hepatitis. Nineteen of the 53 patients (36%) with acute posttransfusion hepatitis progressed to chronic hepatitis. Development of chronic hepatitis was not related to the age or sex of the patient, the incubation period of the preceding acute hepatitis, the presence of shock or malignancy, or the number of units of blood transfused. Patients with higher levels of alanine aminotransferase during the acute hepatitis were more prone to develop chronic hepatitis. The finding of 9.2% of transfusion-related hepatitis in recipients of hepatitis B surface antigen-screened blood from volunteer donors underscores the potential sequelae of blood transfusion, especially as a source of contribution to the pool of chronic liver disease.

Entities:  

Mesh:

Year:  1988        PMID: 3134269     DOI: 10.1016/0016-5085(88)90505-7

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  6 in total

1.  Prophylactic transfusion of platelets and plasma in trauma care.

Authors:  D J Ferguson; L D Wadsworth
Journal:  CMAJ       Date:  1990-05-15       Impact factor: 8.262

2.  The epidemiology of hepatitis C in a UK health regional population of 5.12 million.

Authors:  A H Mohsen
Journal:  Gut       Date:  2001-05       Impact factor: 23.059

3.  A Canadian hospital-based HIV/hepatitis C look-back notification program.

Authors:  N Heddle; J G Kelton; F Smaill; K Foss; J Everson; C Janzen; C Walker; M Jones; D Hammons
Journal:  CMAJ       Date:  1997-07-15       Impact factor: 8.262

4.  Hepatitis B Infection in Canada: Epidemiology and implications for control.

Authors:  G Delage; A O Carter
Journal:  Can Fam Physician       Date:  1992-11       Impact factor: 3.275

5.  Incidence, prevalence, and clinical course of hepatitis C following liver transplantation.

Authors:  G Shah; A J Demetris; J S Gavaler; J H Lewis; S Todo; T E Starzl; D H Van Thiel
Journal:  Gastroenterology       Date:  1992-07       Impact factor: 22.682

6.  Hepatitis C-virus (HCV) antibodies in patients after kidney transplantation.

Authors:  P Baur; V Daniel; S Pomer; H Scheurlen; G Opelz; D Roelcke
Journal:  Ann Hematol       Date:  1991 Feb-Mar       Impact factor: 3.673

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.